These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37657018)

  • 21. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
    Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
    Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of fatty acid desaturase 3 predicts poor prognosis in head and neck squamous cell carcinoma.
    Su K; Wang Y; Gu H; Ma L; Xuan G
    Medicine (Baltimore); 2022 Dec; 101(49):e32119. PubMed ID: 36626435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics analysis of DNMT1 expression and its role in head and neck squamous cell carcinoma prognosis.
    Cui J; Zheng L; Zhang Y; Xue M
    Sci Rep; 2021 Jan; 11(1):2267. PubMed ID: 33500531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
    Zhong Q; Zhou L; Zhu D
    J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics analysis of CUL2/4A/9 and its function in head and neck squamous cell carcinoma.
    Xu B; Wang R; Zhang J; Wang L; Cui X; Chai F; Du X; Jiang Y
    Endokrynol Pol; 2023; 74(3):315-330. PubMed ID: 37695034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive bioinformatics analyses identified Homeobox B9 as a potential prognostic biomarker and therapeutic target for gastric cancer.
    Li X; Chen S; Zhu Y; Fei J; Song L; Sun G; Niu W; Guo L; Wang J
    J Gastrointest Oncol; 2021 Oct; 12(5):2132-2149. PubMed ID: 34790380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma.
    Liu S; Wang Z
    Dis Markers; 2022; 2022():2561673. PubMed ID: 35664436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma.
    Darda L; Hakami F; Morgan R; Murdoch C; Lambert DW; Hunter KD
    PLoS One; 2015; 10(4):e0122285. PubMed ID: 25860510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of CAV1 and CAV2 in Head and Neck Squamous Cell Carcinoma.
    He J; Ouyang S; Zhao Y; Liu Y; Liu Y; Zhou B; Man Q; Liu B; Wu T
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
    Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
    Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLC20A1 is a prospective prognostic and therapy response predictive biomarker in head and neck squamous cell carcinoma.
    Qian X; Jin M; Bei Y; Zhou C; Fang S; Liu K
    Aging (Albany NY); 2024 Feb; 16(5):4423-4444. PubMed ID: 38412319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
    Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
    Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
    Baysal H; Siozopoulou V; Zaryouh H; Hermans C; Lau HW; Lambrechts H; Fransen E; De Pauw I; Jacobs J; Peeters M; Pauwels P; Vermorken JB; Smits E; Lardon F; De Waele J; Wouters A
    Front Immunol; 2022; 13():1001161. PubMed ID: 36268020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IKZF3 is a novel prognostic biomarker for head and neck squamous cell carcinoma: A study based on bioinformatics analysis.
    Li H; Ye M; Hu Z; Lu H; Zheng D; Wu M; Ge T; Xu S; Ge Z; Zhang S; Xu G; Chen H
    Medicine (Baltimore); 2023 Mar; 102(11):e33124. PubMed ID: 36930079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pan-cancer analysis of Homeobox B9 as a predictor for prognosis and immunotherapy in human tumors.
    Jin Q; Xu L; Wang J; Lin J; Lin H
    Aging (Albany NY); 2023 Jun; 15(11):5096-5124. PubMed ID: 37301547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer.
    Li L; Wang XL; Lei Q; Sun CZ; Xi Y; Chen R; He YW
    Sci Rep; 2020 Apr; 10(1):6395. PubMed ID: 32286381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis.
    Shen M; Zhou Z; Li BB; Lv M; Feng C; Chen S; Shi S; Kang M; Zhao T
    Technol Cancer Res Treat; 2022; 21():15330338221081245. PubMed ID: 35235474
    [No Abstract]   [Full Text] [Related]  

  • 39. SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma.
    Yang ML; Zhang JH; Li S; Zhu R; Wang L
    Pathol Oncol Res; 2021; 27():1609967. PubMed ID: 34840533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma.
    Qiu L; Tao A; Sun X; Liu F; Ge X; Li C
    Oncol Res; 2023; 31(5):715-752. PubMed ID: 37547764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.